glp 1 agonist pcos Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? | Journal of Endocrinological Investigation GLP-1s Lead to Greater Weight
Description
Information extracted from eligible articles that were tracked by the reviewers included data such as article title, authors, journal name, year of publication, article type, data source, clinical setting, patient demographics, prior patient pulmonary or gastric history, patient medications noted, system-based comorbidities, extent of adverse event, diagnostics used, study methods, study of patient outcomes, limitations, and conclusions

[DOI] [PMC free article] [PubMed] [Google Scholar] 33.Gros R, You X, Baggio LL, Kabir MG, Sadi AM, Mungrue IN, et al

Real-world evidence on the utilization, clinical and comparative effectiveness, and adverse effects of newer GLP-1RA-based weight-loss therapies

Weight alone isn't enough

Sun Y, Liang Y, Li Z, Xia N
